FILE:BDX/BDX-8K-20031125121234.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 25, 2003 ----------------- BECTON, DICKINSON AND COMPANY - ------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - ------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - ------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - ------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.)
Item 5. Other Events and Regulation FD Disclosure. On November 24, 2003, the Registrant issued the press release that is attached hereto as Exhibit 99.1. Item 7. Financial Statements and Exhibits. (c) Exhibits. Exhibit 99.1 Press release dated November 24, 2003.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Dean J. Paranicas -------------------------------- Dean J. Paranicas Vice President, Corporate Secretary and Public Policy Date: November 25, 2003
INDEX TO EXHIBITS ----------------- Exhibit Number Description of Exhibits ------ ----------------------- 99.1 Press release dated November 24, 2003.

1 Becton Drive Franklin Lakes, NJ 07417 www.bd.com News Release [BECTON, DICKINSON LOGO] Contact: Charles Borgognoni, Corporate Communications - 201-847-6651 Patricia Spinella, Investor Relations - 201-847-5453 BD BOARD DECLARES DIVIDEND INCREASE OF 50% Franklin Lakes, NJ (November 24, 2003) -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 15 cents per common share, an increase of 50% from the previous quarter. The dividend will be payable on January 2, 2004 to holders of record on December 12, 2003. The current annual dividend rate is 60 cents per share, a rise of 50% from a year ago. "The dividend increase reflects the Company's sustained strong performance and cash flow, as well as the confidence we have in our business moving forward," said Edward J. Ludwig, BD Chairman, President and Chief Executive Officer. "We are especially pleased that these achievements continue to create enhanced value for our shareholders." BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2003, BD reported total revenues of $4.528 billion. * * * This press release may contain certain forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future revenues, products and income, or events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; uncertainties of litigation; BD's ability to achieve sales and earnings forecasts, which are based on sales volume and product mix assumptions, to achieve its cost savings objectives, and to achieve anticipated synergies and other cost savings in connection with acquisitions; changes in regional, national or foreign economic conditions; increases in energy costs; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; changes in interest or foreign currency exchange rates; delays in product introductions; and changes in health care or other governmental regulation, as well as other factors discussed in this press release and in BD's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements.


